Participants note personal improvements in knee pain and function while using GLP-1s, some after substantial weight reduction. Several posts reference studies suggesting direct effects on inflammation and cartilage cells via GLP-1 receptors present in chondrocytes. The discussion distinguishes weight-loss benefits from additional mechanisms and questions whether gains persist after stopping treatment.
What this discussion establishesWhether earlier studies already isolated non-weight-loss effects or simply confirmed the expected impact of reduced joint loading.
Still openWhether stopping GLP-1s causes loss of the cartilage or anti-inflammatory benefits independent of weight.
Nothing here is advice.
Interesting, I have osteoarthritis and noticed a big drop in my knee pain and better overall knee function after dropping just over six stone in roughly ten months. I had put the gains down to the weight coming off, but maybe the GLP-1s themselves added something extra.
It is always interesting when these outlets treat something about GLP-1 use as brand new. The clinical work on semaglutide and knee OA pain came out a year and a half ago.
There is a real difference between the two pieces of work. The one funded by the maker ties improvement mainly to weight loss, which is no surprise given the usual four-pound knee-load reduction per pound lost. The newer study points to effects the drugs produce that go beyond weight change, including cartilage remodeling that earlier trials did not show. I fall into several of the overlap groups and am watching this closely.
Same here, and I am also following the work with real interest.
From my own results after nine months and forty-nine pounds lost, BMI is now under twenty-six and body fat dropped from the mid-twenties to 18.5 percent while muscle increased. Apnea is gone, no more CPAP, afib meds stopped, knee pain and weakness gone with only minor crackle left on stairs, and binge drinking has ended. I keep reading the studies to figure out what else the receptors are connected to, because weight loss by itself does not explain it all.
Thanks, I checked the study again and it was not the one I had in mind. I will have to hunt for the article I was thinking of. It might have been about sleep apnea instead of arthritis, though I thought it covered both. I had wondered how researchers would separate the weight-loss part from any direct effect.
Agreed completely. When I saw the earlier paper and that it came from the maker, my first reaction was basically well of course. They might as well have studied whether the drugs affect clothing size.
Yes, tirzepatide has shown strong anti-inflammatory action for a while now. Most of us probably assume any pain drop comes only from the weight loss, but these drugs seem to give older people with arthritis extra help.
The proposed mechanism in that Cell paper is striking. GLP-1 receptors show up on many cell types beyond the pancreas and gut. The work found chondrocytes carry them too, so the drugs can act right on cartilage cells. The main action looks anti-inflammatory rather than metabolic.
That list caught my eye, especially the part about arthritis pain. I do not need to lose weight so I am cautious about dropping too far, but the other benefits sound strong. My knees have been bad since my teens and keep getting worse. Which medication gave you those results?
Currently on retatrutide and about to switch to tirzepatide.
Can I ask why? Plenty of people move the other way. The phase-three numbers for retatrutide and osteoarthritis looked quite good.
This is a useful study with practical implications. One key question it raises is whether the benefits that are separate from weight loss disappear once the medication stops. A follow-up trial on that point could argue for keeping people on it for osteoarthritis even after weight goals are met.
Do you think this effect is limited to semaglutide or would the others produce it too?
The mouse model in the study suggests protection comes through a pathway activated in chondrocytes. Because those cells have GLP-1 receptors, any drug that turns the receptors on should trigger the same pathway and give the same benefit.
It really is striking how many different ways these medications seem to help people.
I went back from retatrutide to tirzepatide because the hunger control was weaker on the first one.
I am curious about that part too. Would it mainly act like an anti-inflammatory, or does it actually help repair the tissue?
If you have tried it, this topic is still open. Sign in to reply — it takes a minute.